Journal article

Investigations into the inhibitory effects of relaxin on renal myofibroblast differentiation

CS Samuel, I Mookerjee, ML Halls, RJ Summers, E Chew, RAD Bathgate, GW Tregear, TD Hewitson

Annals of the New York Academy of Sciences | BLACKWELL PUBLISHING | Published : 2009

Abstract

Derived from fibroblasts, myofibroblasts are the principal cells that are responsible for the synthesis and reorganization of excess matrix in renal interstitial fibrosis. Recognized from their de novo expression of α-smooth muscle actin, myofibroblast differentiation and activity can be influenced by several factors, including a combination of growth factors and other soluble mediators, extracellular matrix components, and mechanical stress. Relaxin has previously been shown to inhibit renal myofibroblast differentiation in vitro, an effect partly mediated through its ability to interfere with the transforming growth factor-β1 (TGF-β1r∥ pathway via inhibition of Smad2 phosphorylation and tr..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Australian Research Council linkage


Funding Acknowledgements

This study was Supported by a National Heart Foundation of Australia/National Health & Medical Research Council (NHMRC) RD VVright Fellowship to C. S. Samuel, a Howard Florey Institute Postgraduate Scholarship to I. Mookerjee, an Australian Postgraduate Scholarship to M. L. Halls, NHMRC Senior Research Fellowships to R. A. D. Bathgate and G. 1,V Tregear, and an Australian Research Council linkage grant (LP05606020).